πŸ‡ΊπŸ‡Έ FDA
Patent

US 8410087

Indole compound

granted A61PA61P3/00A61P3/04

Quick answer

US patent 8410087 (Indole compound) held by Takeda Pharmaceutical Company Limited expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P3/00, A61P3/04, A61P3/10, A61P43/00